By www.reliablemarketforecast.com
Global Non-Alcoholic Steatohepatitis (NASH) Therapeutics And Diagnostics Market Size, Status And Forecast 2024-2031 Story
106
$ 3900
Non-Alcoholic Steatohepatitis (NASH) Therapeutics And Diagnostics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Siemens Healthcare Celerion ZyVersa Therapeutics, Inc. Cisbio Regeneron Pharmaceuticals, Inc. BioPredictive Echosens Genfit Enterome NGM Biopharmaceuticals